GENE CONSTRUCT COMPRISING NUCLEOTIDES ENCODING DECOY PEPTIDES FOR INHIBITING PROTEIN PHOSPHATASE 1-MEDIATED DEPHOSPHORYLATION OF PHOSPHOLAMBAN AND NUCLEOTIDES ENCODING CCN5 PROTEIN OR FRAGMENTS THEREOF, AND USE THEREOF

The present invention relates to: a gene construct comprising nucleotides encoding decoy peptides for inhibiting protein phosphatase 1 (PP1)-medicated dephosphorylation of phospholamban (PLB) and nucleotides encoding the CCN5 protein or a fragment thereof; and a pharmaceutical composition for preven...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KWAK, Taehwan, JANG, Seung Pil
Format: Patent
Sprache:eng ; fre ; kor
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to: a gene construct comprising nucleotides encoding decoy peptides for inhibiting protein phosphatase 1 (PP1)-medicated dephosphorylation of phospholamban (PLB) and nucleotides encoding the CCN5 protein or a fragment thereof; and a pharmaceutical composition for preventing and treating heart diseases, the pharmaceutical composition comprising same. The pharmaceutical composition for preventing and treating heart diseases according to the present invention simultaneously expresses a decoy peptide inhibiting PP1-mediated dephosphorylation and the CCN5 protein, thereby exhibiting a synergistic therapeutic effect, and thus can be effectively used for preventing or treating heart diseases. La présente invention concerne : une construction génique comprenant des nucléotides codant pour des peptides leurres pour inhiber la déphosphorylation médiée par la protéine phosphatase 1 (PP1) de phospholamban (PLB) et des nucléotides codant pour la protéine CCN5 ou un fragment de celle-ci ; et une composition pharmaceutique pour prévenir et traiter des maladies cardiaques, la composition pharmaceutique la comprenant. La composition pharmaceutique pour prévenir et traiter des maladies cardiaques selon la présente invention exprime simultanément un peptide leurre inhibant la déphosphorylation médiée par PP1 et la protéine CCN5, présentant ainsi un effet thérapeutique synergique, et peut ainsi être efficacement utilisée pour prévenir ou traiter des maladies cardiaques. 본 발명은 포스포람반(PLB)의 단백질 포스파타아제 1(PP1)-매개 탈인산화를 억제하는 데코이 펩타이드를 암호화하는 뉴클레오타이드; 및 CCN5 단백질 또는 이의 단편을 암호화하는 뉴클레오타이드를 포함하는 유전자 컨스트럭트 및 이를 포함하는 심장 질환의 예방 및 치료용 약학 조성물에 관한 것이다. 본 발명의 심장 질환 예방 및 치료용 약학 조성물은 PP1-매개 탈인산화를 억제하는 데코이 펩타이드와 CCN5 단백질을 동시에 발현시켜 상승적 치료 효과를 발휘하여 심장 질환을 예방 또는 치료하는데 유용하게 사용될 수 있다.